229 related articles for article (PubMed ID: 24028901)
41. Associations of adiponectin with paraoxonase 1 and sE-selectin in hemodialyzed patients.
Peti A; Csiky B; Guth E; Kenyeres P; Varga Z; Seres I; Jeney Z; Juhasz M; Mezosi E; Paragh G; Kovacs GL; Bajnok L
Kidney Blood Press Res; 2009; 32(5):360-5. PubMed ID: 19887823
[TBL] [Abstract][Full Text] [Related]
42. Paraoxonase levels in women with polycystic ovary syndrome.
Fenkci IV; Serteser M; Fenkci S; Kose S
J Reprod Med; 2007 Oct; 52(10):879-83. PubMed ID: 17977159
[TBL] [Abstract][Full Text] [Related]
43. Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
Zhou M; Liu XH; Liu QQ; Chen M; Bai H; Guan LB; Fan P
J Diabetes Res; 2020; 2020():3483427. PubMed ID: 32090118
[TBL] [Abstract][Full Text] [Related]
44. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
45. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N
Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940
[TBL] [Abstract][Full Text] [Related]
46. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
Leviev I; Kalix B; Brulhart Meynet MC; James RW
Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
[TBL] [Abstract][Full Text] [Related]
47. The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Himbergen TM; van Tits LJ; Voorbij HA; de Graaf J; Stalenhoef AF; Roest M
J Intern Med; 2005 Nov; 258(5):442-9. PubMed ID: 16238680
[TBL] [Abstract][Full Text] [Related]
48. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome.
Maggio AB; Mueller P; Wacker J; Viallon M; Belli DC; Beghetti M; Farpour-Lambert NJ; McLin VA
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):720-6. PubMed ID: 22157928
[TBL] [Abstract][Full Text] [Related]
49. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
Goral J
Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
[TBL] [Abstract][Full Text] [Related]
50. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
51. Increased serum IgG and IgA in overweight children relate to a less favourable metabolic phenotype.
Bassols J; Prats-Puig A; Gispert-Saüch M; Crehuet-Almirall M; Carreras-Badosa G; Díaz-Roldán F; Montesinos-Costa M; de Zegher F; Ibáñez L; López-Bermejo A
Pediatr Obes; 2014 Jun; 9(3):232-8. PubMed ID: 23554403
[TBL] [Abstract][Full Text] [Related]
52. Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values.
Cayir Y; Cayir A; Turan MI; Kurt N; Kara M; Laloglu E; Ciftel M; Yildirim A
Biol Trace Elem Res; 2014 Aug; 160(2):155-60. PubMed ID: 24920129
[TBL] [Abstract][Full Text] [Related]
53. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
54. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
[TBL] [Abstract][Full Text] [Related]
55. Higher hdl levels are a preventive factor for metabolic syndrome in obese Turkish children.
Özer S; Yılmaz R; Özlem Kazanci N; Sönmezgöz E; Karaaslan E; Altuntaş B; Emre Kuyucu Y
Nutr Hosp; 2014 Oct; 31(1):307-12. PubMed ID: 25561123
[TBL] [Abstract][Full Text] [Related]
56. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children.
Çayır A; Turan Mİ; Gurbuz F; Kurt N; Yildirim A
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):551-6. PubMed ID: 25252747
[TBL] [Abstract][Full Text] [Related]
57. Serum paraoxonase 1 activity in women with metabolic syndrome.
Yilmaz H; Sayar N; Yilmaz M; Gurkan U; Sesal C; Tosu R; Cakmak N; Erer B; Oz D; Ciloglu F; Bolca O
Kardiol Pol; 2010 Nov; 68(11):1219-24. PubMed ID: 21108196
[TBL] [Abstract][Full Text] [Related]
58. Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels.
Seres I; Bajnok L; Harangi M; Sztanek F; Koncsos P; Paragh G
Adv Exp Med Biol; 2010; 660():129-42. PubMed ID: 20221876
[TBL] [Abstract][Full Text] [Related]
59. Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.
Parra S; Alonso-Villaverde C; Coll B; Ferré N; Marsillach J; Aragonès G; Mackness M; Mackness B; Masana L; Joven J; Camps J
Atherosclerosis; 2007 Sep; 194(1):175-81. PubMed ID: 16942773
[TBL] [Abstract][Full Text] [Related]
60. Serum Paraoxonase-1 Levels are Significantly Decreased in the Presence of Insulin Resistance.
Gateva A; Assyov Y; Tsakova A; Kamenov Z
Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):444-7. PubMed ID: 27355189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
